1,255
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

LncRNA CRNDE exacerbates neuropathic pain in chronic constriction injury-induced(CCI) rats through regulating miR-146a-5p/WNT5A pathway

ORCID Icon, &
Pages 7348-7359 | Received 29 Apr 2021, Accepted 21 Aug 2021, Published online: 06 Oct 2021

References

  • Nahin RL. Estimates of pain prevalence and severity in adults: united States, 2012. J Pain. 2015;16(8):769–780.
  • Wang Z, Song K, Zhao W, et al. Dendritic cells in tumor microenvironment promoted the neuropathic pain via paracrine inflammatory and growth factors. Bioengineered. 2020;11(1):661–678.
  • Nightingale S. The neuropathic pain market. Nat Rev Drug Discov. 2012;11(2):101–102.
  • Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3(1):17002.
  • Wang C, Gu L, Ruan Y, et al. Facilitation of MrgprD by TRP-A1 promotes neuropathic pain. Faseb J. 2019;33(1):1360–1373.
  • van Hecke O, Austin SK, Khan RA, et al. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654–662.
  • Zhang H, Yu Y, Zhang K, et al. Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis. Bioengineered. 2019;10(1):306–315.
  • Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73(13):2491–2509.
  • Guo ZH, You Z-H, Wang Y-B, et al. A Learning-Based Method for LncRNA-Disease Association Identification Combing Similarity Information and Rotation Forest. iScience. 2019;19:786–795.
  • Xu X, Cui L. Autophagy-Associated lncRNAs: promising Targets for Neurological Disease Diagnosis and Therapy. 2020;2020:8881687.
  • Wu S, Bono J, Tao YX. Long noncoding RNA (lncRNA): a target in neuropathic pain. Expert Opin Ther Targets. 2019;23(1):15–20.
  • Tian Y, Sun L, Qi T. Long noncoding RNA GAS5 ameliorates chronic constriction injury induced neuropathic pain in rats by modulation of the miR-452-5p/CELF2 axis. Can J Physiol Pharmacol. 2020;98(12):870–877.
  • Li H, et al. SNHG16 aggravates chronic constriction injury-induced neuropathic pain in rats via binding with miR-124-3p and miR-141-3p to upregulate JAG1. Brain Res Bull. 2020;165:228–237.
  • Lu Y, et al. CRNDE: an oncogenic long non-coding RNA in cancers. 2020;20:162.
  • Xie H, Ma B, Gao Q, et al. Long non-coding RNA CRNDE in cancer prognosis: review and meta-analysis. Clin Chim Acta. 2018;485:262–271.
  • Zhang D, Mou JY, Wang F. CRNDE enhances neuropathic pain via modulating miR-136/IL6R axis in CCI rat models. 2019;234(12):22234–22241.
  • Prasad CP, Manchanda M, Mohapatra P, et al. WNT5A as a therapeutic target in breast cancer. Cancer Metastasis Rev. 2018;37(4):767–778.
  • Becker J, Wilting J. WNT signaling, the development of the sympathoadrenal-paraganglionic system and neuroblastoma. 2018;75(6):1057–1070.
  • Bem J, Brożko N, Chakraborty C, et al. Wnt/β-catenin signaling in brain development and mental disorders: keeping TCF7L2 in mind. FEBS Lett. 2019;593(13):1654–1674.
  • Simonetti M, Kuner R. Spinal Wnt5a Plays a Key Role in Spinal Dendritic Spine Remodeling in Neuropathic and Inflammatory Pain Models and in the Proalgesic Effects of Peripheral Wnt3a. J Neurosci. 2020;40(35):6664–6677.
  • Kanda H, Kanao M, Liu S, et al. HSV vector-mediated GAD67 suppresses neuropathic pain induced by perineural HIV gp120 in rats through inhibition of ROS and Wnt5a. Gene Ther. 2016;23(4):340–348.
  • Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9(8):807–819.
  • Tan M, Shen L, Hou Y. Epigenetic modification of BDNF mediates neuropathic pain via miR-30a-3p/EP300 axis in CCI rats. Biosci Rep. 2020;40(11). DOI:10.1042/BSR20194442
  • D’Ammando A, Messina G, Franzini A, et al. Peripheral nerve field stimulation for chronic neuropathic pain: a single institution experience. Acta Neurochir (Wien). 2016;158(4):767–772.
  • Ding Y, Yao P, Hong T, et al. Early hyperbaric oxygen effects on neuropathic pain and nitric oxide synthase isoforms in CCI rats. Oncotarget. 2018;9(7):7513–7521.
  • Zhang C, et al. PiRNA-DQ541777 Contributes to Neuropathic Pain via Targeting Cdk5rap1. 2019;39(45):9028–9039.
  • Fischer R, Sendetski M, del Rivero T, et al. TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes. Proc Natl Acad Sci U S A. 2019;116(34):17045–17050.
  • Oe S, Kimura T, Yamada H. Regulatory non-coding RNAs in nervous system development and disease. Front Biosci (Landmark Ed). 2019;24:1203–1240.
  • Malissovas N, Ninou E, Michail A, et al. Targeting Long Non-Coding RNAs in Nervous System Cancers: new Insights in Prognosis, Diagnosis and Therapy. Curr Med Chem. 2019;26(30):5649–5663.
  • Mao P, Li CR, Zhang SZ, et al. Transcriptomic differential lncRNA expression is involved in neuropathic pain in rat dorsal root ganglion after spared sciatic nerve injury. Braz J Med Biol Res. 2018;51(10):e7113.
  • Tang S, Zhou J, Jing H, et al. Functional roles of lncRNAs and its potential mechanisms in neuropathic pain. Clin Epigenetics. 2019;11(1):78.
  • Li Z, Li X, Chen X, et al. Emerging roles of long non-coding RNAs in neuropathic pain. Cell Prolif. 2019;52(1):e12528.
  • Zhang J, Yin M, Peng G, et al. CRNDE: an important oncogenic long non-coding RNA in human cancers. Cell Prolif. 2018;51(3):e12440.
  • Han P, Li J-W, Zhang B-M, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol Cancer. 2017;16(1):9.
  • Tang D, Zhao L, Peng C, et al. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p. J Cell Biochem. 2019;120(9):16128–16142.
  • Gao J, Chen Q, Zhao Y, et al. <p>lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis. Onco Targets Ther. 2020;13:9225–9234.
  • Zheng J, Liu X, Wang P, et al. CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis. Mol Ther. 2016;24(7):1199–1215.
  • Yi M, et al. Downregulated lncRNA CRNDE contributes to the enhancement of nerve repair after traumatic brain injury in rats. 2019;18(18):2332–2343.
  • Guo X, Mu H, Yan S, et al. Exploring the molecular disorder and dysfunction mechanism of human dental pulp cells under hypoxia by comprehensive multivariate analysis. Gene. 2020;735:144332.
  • Shang J, Sun S, Zhang L, et al. miR-211 alleviates ischaemia/reperfusion-induced kidney injury by targeting TGFβR2/TGF-β/SMAD3 pathway. Bioengineered. 2020;11(1):547–557.
  • Bi YN, Guan J-P, Wang L, et al. Clinical significance of microRNA-125b and its contribution to ovarian carcinogenesis. Bioengineered. 2020;11(1):939–948.
  • Forouzanfar F, Shojapour M, Asgharzade S, et al. Causes and Consequences of MicroRNA Dysregulation Following Cerebral Ischemia-Reperfusion Injury. CNS Neurol Disord Drug Targets. 2019;18(3):212–221.
  • Konovalova J, et al. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases. 2019; 20(23)
  • Qing L, et al. Exosomes and Their MicroRNA Cargo: new Players in Peripheral Nerve Regeneration. 2018;32(9):765–776.
  • Iacona JR, Lutz CS. miR-146a-5p: expression, regulation, and functions in cancer. Wiley Interdiscip Rev RNA. 2019;10(4):e1533.
  • Coffey AR, Kanke M, Smallwood TL, et al. microRNA-146a-5p association with the cardiometabolic disease risk factor TMAO. Physiol Genomics. 2019;51(2):59–71.
  • Luo Q, Feng Y, Xie Y, et al. Nanoparticle-microRNA-146a-5p polyplexes ameliorate diabetic peripheral neuropathy by modulating inflammation and apoptosis. Nanomedicine. 2019;17:188–197.
  • Phạm TL, et al. miRNA 146a-5p-loaded poly(d,l-lactic-co-glycolic acid) nanoparticles impair pain behaviors by inhibiting multiple inflammatory pathways in microglia. 2020;15(11):1113–1126.
  • Wang JF, et al. Crocin Alleviates Pain Hyperalgesia in AIA Rats by Inhibiting the Spinal Wnt5a/β-Catenin Signaling Pathway and Glial Activation. 2020;2020:4297483.